VCAM1 and spondylo-ocular syndrome: showed that a composite diagnostic biomarker panel (L-Ficolin, hyaluronic acid (HA), VCAM-1) can identify patients at high risk of SOS as early as the first day after HCT, even before clinical manifestation of SOS (66).